BIOMAT Database Logo BIOMAT Database Logo

Combined intraommaya methotrexate, cytosine arabinoside, hydrocortisone and thio-TEPA for meningeal involvement by malignancies. 1987

D J Stewart, and J A Maroun, and H Hugenholtz, and B Benoit, and A Girard, and M Richard, and N Russell, and L Huebsch, and J Drouin
Ottawa Regional Cancer Centre, General Hospital Division, Ontario, Canada.

Twenty-three adult patients with meningeal involvement by a variety of malignancies were treated with the intra-Ommaya combination of methotrexate, hydrocortisone, cytosine arabinoside, and thio-TEPA. Whole brain irradiation was also administered to most patients who had not previously received it. Most patients demonstrated improvement of cerebrospinal fluid parameters, but only 50% of the patients experienced neurological improvement. Patients who did not receive cranial irradiation and performance status 4 patients were less likely to respond than were patients who did receive cranial irradiation as part of their treatment and patients who were performance status 0-3. Four patients developed possible and 2 patients developed probable or definite serious neurological complications. Another 4 patients developed less severe, reversible neurological toxicity. It is possible (but still uncertain) that this regimen is more toxic than other less intensive regimens, and further studies should be undertaken cautiously.

UI MeSH Term Description Entries
D007276 Injections, Intraventricular Injections into the cerebral ventricles. Intraventricular Injections,Injection, Intraventricular,Intraventricular Injection
D008297 Male Males
D008577 Meningeal Neoplasms Benign and malignant neoplastic processes that arise from or secondarily involve the meningeal coverings of the brain and spinal cord. Intracranial Meningeal Neoplasms,Spinal Meningeal Neoplasms,Benign Meningeal Neoplasms,Leptomeningeal Neoplasms,Malignant Meningeal Neoplasms,Meningeal Cancer,Meningeal Neoplasms, Benign,Meningeal Neoplasms, Intracranial,Meningeal Neoplasms, Malignant,Meningeal Tumors,Neoplasms, Leptomeningeal,Neoplasms, Meningeal,Benign Meningeal Neoplasm,Cancer, Meningeal,Cancers, Meningeal,Intracranial Meningeal Neoplasm,Leptomeningeal Neoplasm,Malignant Meningeal Neoplasm,Meningeal Cancers,Meningeal Neoplasm,Meningeal Neoplasm, Benign,Meningeal Neoplasm, Intracranial,Meningeal Neoplasm, Malignant,Meningeal Neoplasm, Spinal,Meningeal Neoplasms, Spinal,Meningeal Tumor,Neoplasm, Benign Meningeal,Neoplasm, Intracranial Meningeal,Neoplasm, Leptomeningeal,Neoplasm, Malignant Meningeal,Neoplasm, Meningeal,Neoplasm, Spinal Meningeal,Neoplasms, Benign Meningeal,Neoplasms, Intracranial Meningeal,Neoplasms, Malignant Meningeal,Neoplasms, Spinal Meningeal,Spinal Meningeal Neoplasm,Tumor, Meningeal,Tumors, Meningeal
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D003561 Cytarabine A pyrimidine nucleoside analog that is used mainly in the treatment of leukemia, especially acute non-lymphoblastic leukemia. Cytarabine is an antimetabolite antineoplastic agent that inhibits the synthesis of DNA. Its actions are specific for the S phase of the cell cycle. It also has antiviral and immunosuppressant properties. (From Martindale, The Extra Pharmacopoeia, 30th ed, p472) Ara-C,Arabinofuranosylcytosine,Arabinosylcytosine,Cytosine Arabinoside,Aracytidine,Aracytine,Cytarabine Hydrochloride,Cytonal,Cytosar,Cytosar-U,beta-Ara C,Ara C,Arabinoside, Cytosine,Cytosar U,beta Ara C
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006854 Hydrocortisone The main glucocorticoid secreted by the ADRENAL CORTEX. Its synthetic counterpart is used, either as an injection or topically, in the treatment of inflammation, allergy, collagen diseases, asthma, adrenocortical deficiency, shock, and some neoplastic conditions. Cortef,Cortisol,Pregn-4-ene-3,20-dione, 11,17,21-trihydroxy-, (11beta)-,11-Epicortisol,Cortifair,Cortril,Epicortisol,Hydrocortisone, (11 alpha)-Isomer,Hydrocortisone, (9 beta,10 alpha,11 alpha)-Isomer,11 Epicortisol
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

D J Stewart, and J A Maroun, and H Hugenholtz, and B Benoit, and A Girard, and M Richard, and N Russell, and L Huebsch, and J Drouin
[Prolongatoon of homotransplant viability under the influence of thio-TEPA and thio-TEPA combined with hydrocortisone].
August 1969, Biulleten' eksperimental'noi biologii i meditsiny,
D J Stewart, and J A Maroun, and H Hugenholtz, and B Benoit, and A Girard, and M Richard, and N Russell, and L Huebsch, and J Drouin
The effect of pretreatment with thio-TEPA and cytosine arabinoside on megakaryocytopoiesis in rats given a sublethal dose of thio-TEPA.
January 1987, Blut,
D J Stewart, and J A Maroun, and H Hugenholtz, and B Benoit, and A Girard, and M Richard, and N Russell, and L Huebsch, and J Drouin
[Ventriculo-lumbar perfusion chemotherapy with methotrexate and cytosine arabinoside for meningeal dissemination of malignant disease].
June 1991, Gan to kagaku ryoho. Cancer & chemotherapy,
D J Stewart, and J A Maroun, and H Hugenholtz, and B Benoit, and A Girard, and M Richard, and N Russell, and L Huebsch, and J Drouin
Interaction of methotrexate and cytosine arabinoside.
December 1972, Lancet (London, England),
D J Stewart, and J A Maroun, and H Hugenholtz, and B Benoit, and A Girard, and M Richard, and N Russell, and L Huebsch, and J Drouin
Ventriculolumbar perfusion chemotherapy with methotrexate and cytosine arabinoside for meningeal carcinomatosis: a pilot study in 13 patients.
March 1996, Surgical neurology,
D J Stewart, and J A Maroun, and H Hugenholtz, and B Benoit, and A Girard, and M Richard, and N Russell, and L Huebsch, and J Drouin
Thio-TEPA and methotrexate chemotherapy of advanced ovarian carcinoma.
January 1968, Journal of the Mount Sinai Hospital, New York,
D J Stewart, and J A Maroun, and H Hugenholtz, and B Benoit, and A Girard, and M Richard, and N Russell, and L Huebsch, and J Drouin
Cyclophosphamide, cytosine arabinoside and methotrexate versus cytosine arabinoside and thioguanine for acute non-lymphocytic leukemia in adults.
January 1980, Cancer,
D J Stewart, and J A Maroun, and H Hugenholtz, and B Benoit, and A Girard, and M Richard, and N Russell, and L Huebsch, and J Drouin
Combined therapeutic trial in multiple sclerosis: hydrocortisone hemisuccinate with cyclophosphamide or cytosine arabinoside.
January 1973, Acta neurologica Belgica,
D J Stewart, and J A Maroun, and H Hugenholtz, and B Benoit, and A Girard, and M Richard, and N Russell, and L Huebsch, and J Drouin
[Synoviorthesis by thio-tepa].
January 1968, Revue du rhumatisme et des maladies osteo-articulaires,
D J Stewart, and J A Maroun, and H Hugenholtz, and B Benoit, and A Girard, and M Richard, and N Russell, and L Huebsch, and J Drouin
Comparison of intrathecal chemotherapy for leptomeningeal carcinomatosis of a solid tumor: methotrexate alone versus methotrexate in combination with cytosine arabinoside and hydrocortisone.
December 2003, Japanese journal of clinical oncology,
Copied contents to your clipboard!